Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention. - Wikidata - thesis-toulmin - TriplyDB

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.

http://www.wikidata.org/entity/Q38905356

about

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine.Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.Population Pharmacokinetics of the Antimalarial Amodiaquine: A Pooled Analysis to Optimize Dosing

P2860

Q26830528-005010B2-59B0-4168-AEF6-4C5E29C570BA Q31153944-06FC035E-1483-48D5-B8D2-C628A6128EDF Q33601831-66973A6E-A1B7-497A-8713-0C40C42E3219 Q36018444-D6EF89B8-ECEF-4A3C-84B3-EB6472F92DEE Q36075976-4D1B3E1A-05DD-47A8-8077-E8C7E5161FED Q36092227-646E5811-1805-42CB-910E-3D5A94E740A0 Q38684764-42CE893C-202F-4A0E-AF3D-0B3A59A9E7E4 Q56358106-35AB7573-E3C1-4B53-A813-73426A3833A9

P2860

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.

http://www.wikidata.org/entity/Q38905356

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Characterization of an in vivo ...... ne in malaria chemoprevention.

@en

type

label

Characterization of an in vivo ...... ne in malaria chemoprevention.

@en

prefLabel

Characterization of an in vivo ...... ne in malaria chemoprevention.

@en

P1433

Q38905356-26E0678F-43D8-4FE7-AEC1-E3096384EF1A

P1476

Q38905356-E7746774-005D-49B4-80FF-7540FA78FD39

P2093

Q38905356-E4FD1577-0D1C-4D35-94FA-AB5010C408C4

P2860

Q38905356-0C2950BE-015B-44EB-A7DE-EABD76CEE461

Q38905356-1690D02F-0016-4848-B29B-7ED98E8A0430

Q38905356-18F0E016-8FEC-447C-8420-E127EED5EC4F

Q38905356-28103927-A8D8-4486-B2A6-5AA66F795D77

Q38905356-4391EB35-8151-48D5-B26C-70FE7211BDE0

Q38905356-43B60FCC-9A9A-413A-83E9-17C1E8128473

Q38905356-44158076-1EDA-4077-9D27-3EF290F44545

Q38905356-4569C316-C2DD-4C18-AE2F-0F30E2D66F59

Q38905356-4AF6753F-382F-4286-A37B-EC6FB25DCAAD

Q38905356-4CC97228-32D4-43E5-90B7-3F1B6A1F2D3D

P304

Q38905356-31570ACD-B4E8-4ABC-8D12-F78108E610DA

P31

Q38905356-20BBCDF3-70F4-4222-A30F-A463B8D9D83B

P356

Q38905356-E0C02616-595C-44E3-9845-1B05D9BEF038

P407

Q38905356-69E597EE-A645-4599-99FE-87CD8ADBCB22

P433

Q38905356-4E2BE733-F49D-4F46-BB0F-E12ADC883FB4

P478

Q38905356-7554D2BB-EF42-4741-8DE2-86F4A81B03E3

P50

Q38905356-70343D41-131D-44DF-A7CC-50C8DF6C6224

Q38905356-A04637C8-DD6A-4C7E-AB71-ACFBFF644B15

Q38905356-C36F9B2E-6C00-425A-8419-3D502933D7ED

Q38905356-E41A8FEE-C27D-4E36-8782-F5381B53B1B3

Q38905356-F5109B46-9332-4F1F-A525-ECA1F2AC9C39

P577

Q38905356-9C2E2D19-71B6-4D75-B0AF-B475EFF3A147

P698

Q38905356-D50E1C73-BBF4-4146-9637-27568BC8883C

P921

Q38905356-154B009F-0989-4052-8728-B1DD6B0818F9

P356

SCITRANSLMED.3005311

P1433

Science Translational Medicine

P1476

Characterization of an in vivo ...... ne in malaria chemoprevention.

@en

P2093

Mats O Karlsson

http://www.w3.org/2001/XMLSchema#string

P2860

Intermittent presumptive treatment for malaria

Use of prior information to stabilize a population data analysis.

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.

Handling data below the limit of quantification in mixed effect models.

Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.

Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.

The dynamics of naturally acquired immunity to Plasmodium falciparum infection

Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites.

Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa.

P304

260ra147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005311

http://www.w3.org/2001/XMLSchema#string

P407

P433

260

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Martin Bergstrand

Khin Maung Lwin

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25355697

http://www.w3.org/2001/XMLSchema#string

P921